Farraye FA - Search Results

1

Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.

Fiske HW, Ward C, Shah SA, Holubar SD, Al-Bawardy B, Barnes EL, Binion D, Bohm M, Brand M, Clarke K, Cohen BL, Cross RK, Dueker J, Engels M, Farraye FA, Fine S, Forster E, Gaidos J, Ginsburg P, Goyal A, Hanson J, Herfath H, Hull T, Kelly CR, Lazarev M, Levy LC, Melia J, Philpott J, Qazi T, Siegel CA, Watson A, Wexner SD, Williams ED, Regueiro M. Fiske HW, et al. Among authors: farraye fa. Crohns Colitis 360. 2024 Apr 11;6(2):otae022. doi: 10.1093/crocol/otae022. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38720935 Free PMC article.

2

Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019.

Alsakarneh S, Ahmed M, Jaber F, Abuassi M, Mourad FH, Francis FF, Barada K, Tfayli R, Al-Bawardy B, Farraye FA, Hashash JG. Alsakarneh S, et al. Among authors: farraye fa. Ann Gastroenterol. 2024 Sep-Oct;37(5):527-535. doi: 10.20524/aog.2024.0909. Epub 2024 Aug 19. Ann Gastroenterol. 2024. PMID: 39238799 Free PMC article.

3

Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel.

ASGE IBD Endoscopy Consensus Panel; Shen B, Abreu MT, Cohen ER, Farraye FA, Fischer M, Feuerstadt P, Kapur S, Ko HM, Kochhar GS, Liu X, Mahadevan U, McBride DL, Navaneethan U, Regueiro M, Ritter T, Sharma P, Lichtenstein GR. ASGE IBD Endoscopy Consensus Panel, et al. Among authors: farraye fa. Gastrointest Endosc. 2025 Feb;101(2):295-314. doi: 10.1016/j.gie.2024.08.034. Epub 2024 Oct 18. Gastrointest Endosc. 2025. PMID: 39425706

4

Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis.

Kochhar GS, Khataniar H, Hashash JG, Tabaku F, Regueiro M, Farraye FA, Desai A. Kochhar GS, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2025 Jul 7;31(7):1868-1875. doi: 10.1093/ibd/izae251. Inflamm Bowel Dis. 2025. PMID: 39478367

5

Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease.

Fiorino G, Ananthakrishnan A, Cohen RD, Cross RK, Deepak P, Farraye FA, Halfvarson J, Steinhart AH. Fiorino G, et al. Among authors: farraye fa. J Clin Med. 2025 Feb 26;14(5):1561. doi: 10.3390/jcm14051561. J Clin Med. 2025. PMID: 40095484 Free PMC article. Review.

6

Natural History, Treatment Persistence and Predictors of Treatment Failure in Patients With Ulcerative Colitis on 5-Aminosalicylic Acid: A US Population-Level Cohort Study.

Kochhar GS, Khataniar H, Hashash JG, Regueiro M, Farraye FA, Desai A. Kochhar GS, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2025 Nov 1;31(11):3069-3076. doi: 10.1093/ibd/izaf129. Inflamm Bowel Dis. 2025. PMID: 40554593

7

Recombinant herpes zoster vaccine lowers shingles complication risk in patients with inflammatory bowel disease.

Wang Y, Huang Y, Hashash JG, Odah T, Hayney M, Caldera F, Farraye FA. Wang Y, et al. Among authors: farraye fa. J Crohns Colitis. 2025 Sep 7;19(8):jjaf116. doi: 10.1093/ecco-jcc/jjaf116. J Crohns Colitis. 2025. PMID: 40623013

8

Cannabis use in Patients With Inflammatory Bowel Disease is Associated With Longer Endoscopic Duration and Endoscopic Inflammation.

Loeb L, Hochwald A, Picco MF, Chan JL, Hashash JG, Chadha R, Farraye FA, Kinnucan JA. Loeb L, et al. Among authors: farraye fa. Crohns Colitis 360. 2025 Jul 2;7(3):otaf034. doi: 10.1093/crocol/otaf034. eCollection 2025 Jul. Crohns Colitis 360. 2025. PMID: 40667460 Free PMC article.

9

Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis.

Desai A, Habib H, Khataniar H, Farraye FA, Sehgal P, Barnes EL, Kochhar GS, Hashash JG. Desai A, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2025 Dec 9:izaf301. doi: 10.1093/ibd/izaf301. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 41365321

10

Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease.

Desai A, Petrov J, Hashash JG, Patel H, Brahmbhatt B, Kochhar GS, Farraye FA. Desai A, et al. Among authors: farraye fa. Aliment Pharmacol Ther. 2024 Sep;60(5):620-632. doi: 10.1111/apt.18138. Epub 2024 Jun 27. Aliment Pharmacol Ther. 2024. PMID: 38938071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters